Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03761121 · ClinicalTrials.gov registry record · NA
Developing Fast Pediatric Imaging
A NA study of Pediatric Low-grade Gliomas, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT03761121: Recruiting NA study of Pediatric Low-grade Gliomas, sponsored by Boston Children's Hospital.
NCT03761121 is a NA study of Pediatric Low-grade Gliomas that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03761121, a NA study of Pediatric Low-grade Gliomas, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research study is evaluating the investigational software for magnetic resonance imaging (MRI) systems and techniques to process magnetic resonance (MR) images
Primary Outcome
The outcome measure for this project will be that the rapid scan from Wave-CAIPI can provide equivalent diagnostic quality to that of standard clinical acquisitions which is performed at much slower speed. This will be assess using visual qualitative assessment by experienced radiologists on the project.
Conditions Studied
Interventions
- OTHER Wave-CAIPI
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
- Boston Children Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2028-03-01 |
| Phase | NA |
What NCT03761121 shows while recruiting
NCT03761121 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Pediatric Low-grade Gliomas appearing as the primary indexed condition, and to 1 intervention - of which Wave-CAIPI is the first listed.
NCT03761121 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03761121 about?
NCT03761121 is a clinical study titled "Developing Fast Pediatric Imaging". This research study is evaluating the investigational software for magnetic resonance imaging (MRI) systems and techniques to process magnetic resonance (MR) images
What is the current status of trial NCT03761121?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2019-04-15. Estimated completion is 2028-03-01.
What conditions does trial NCT03761121 study?
This clinical trial studies the following conditions: Pediatric Low-grade Gliomas.
What interventions are being tested in trial NCT03761121?
The interventions under investigation include: Wave-CAIPI (OTHER).
Who is sponsoring clinical trial NCT03761121?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03761121 being conducted?
This trial has 3 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03761121's enrollment target sits among peer trials
300 330th of 2000 higher than 1,631 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI